Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 51.9
(0.31%)
CNY 51.9
(0.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1 Billion CNY | 215.28% |
| 2022 | 320.19 Million CNY | 282.78% |
| 2021 | 83.64 Million CNY | -66.77% |
| 2020 | 251.72 Million CNY | 25.49% |
| 2019 | 200.58 Million CNY | 125.72% |
| 2018 | 88.86 Million CNY | -32.92% |
| 2017 | 132.47 Million CNY | 25.05% |
| 2016 | 105.93 Million CNY | 47.75% |
| 2015 | 71.7 Million CNY | 88.68% |
| 2014 | 38 Million CNY | -60.84% |
| 2013 | 97.03 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.14 Billion CNY | 13.49% |
| 2024 Q3 | 1.23 Billion CNY | 3.54% |
| 2024 Q2 | 1.22 Billion CNY | 6.63% |
| 2023 FY | 1 Billion CNY | 215.28% |
| 2023 Q2 | 436.32 Million CNY | 4.17% |
| 2023 Q3 | 509.38 Million CNY | 16.75% |
| 2023 Q4 | 1 Billion CNY | 98.18% |
| 2023 Q1 | 418.87 Million CNY | 30.82% |
| 2022 Q3 | 300.01 Million CNY | -0.79% |
| 2022 Q2 | 302.4 Million CNY | 100.97% |
| 2022 Q1 | 150.47 Million CNY | 79.88% |
| 2022 FY | 320.19 Million CNY | 282.78% |
| 2022 Q4 | 320.19 Million CNY | 6.72% |
| 2021 Q4 | 83.64 Million CNY | 28.41% |
| 2021 Q1 | 239.93 Million CNY | -4.68% |
| 2021 FY | 83.64 Million CNY | -66.77% |
| 2021 Q3 | 65.14 Million CNY | -4.46% |
| 2021 Q2 | 68.18 Million CNY | -71.58% |
| 2020 FY | 251.72 Million CNY | 25.49% |
| 2020 Q4 | 251.72 Million CNY | 0.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q2 | 271.75 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q3 | 144.42 Million CNY | 10.82% |
| 2019 Q2 | 130.32 Million CNY | 18.74% |
| 2019 Q4 | 200.58 Million CNY | 38.89% |
| 2019 FY | 200.58 Million CNY | 125.72% |
| 2019 Q1 | 109.74 Million CNY | 23.5% |
| 2018 Q2 | 132.47 Million CNY | 0.0% |
| 2018 Q1 | 132.47 Million CNY | -36.84% |
| 2018 FY | 88.86 Million CNY | -32.92% |
| 2018 Q4 | 88.86 Million CNY | -38.64% |
| 2018 Q3 | 144.83 Million CNY | 9.33% |
| 2017 FY | 132.47 Million CNY | 25.05% |
| 2017 Q4 | 209.73 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q4 | 78 Million CNY | 0.0% |
| 2016 Q2 | 84.8 Million CNY | 0.0% |
| 2016 Q3 | 78 Million CNY | -8.02% |
| 2016 FY | 105.93 Million CNY | 47.75% |
| 2016 Q1 | 84.8 Million CNY | 18.27% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 71.7 Million CNY | 0.0% |
| 2015 FY | 71.7 Million CNY | 88.68% |
| 2015 Q3 | 71.7 Million CNY | 0.0% |
| 2014 FY | 38 Million CNY | -60.84% |
| 2013 FY | 97.03 Million CNY | 0.0% |